Haydn Kissick
0000-0001-7624-5598
Publication & Citation Trends
Publications
0 total
Abstract A015: Phase II trial of perioperative Lenvatinib plus Pembrolizumab in locally advanced nonmetastatic clear cell renal cell carcinoma
Cited by 0
Semantic Scholar
An increase in splenic volume after first-line immunotherapy is associated with worse PFS in patients with metastatic renal cell carcinoma
Cited by 0
Semantic Scholar
896 Clinicopathologic Analysis of Patients Receiving Neoadjuvant Lenvatinib and Pembrolizumab for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma
Cited by 0
Semantic Scholar
Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustion
Cited by 0
Semantic Scholar
Long-term efficacy and patient experience with neoadjuvant cabozantinib for locally advanced renal cell carcinoma.
Cited by 0
Semantic Scholar
Expansion and mobilization of virus-specific stem-like CD8 T cells in chronic viral infection after treatment with a long-acting IL-7, NT-I7
Cited by 0
Semantic Scholar
Cancer cell-intrinsic mechanisms controlling the immune response to non-muscle-invasive bladder cancer 3077
Cited by 0
Semantic Scholar
High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Signatures Between Primary and Metastatic Pancreatic Ductal Adenocarcinoma
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(116)
Immunotherapy and Immune Responses
(66)
Immune Cell Function and Interaction
(52)
CAR-T cell therapy research
(44)
Pancreatic and Hepatic Oncology Research
(36)
Affiliations
Beth Israel Deaconess Medical Center
Emory Healthcare
Harvard University
Emory University
Emory and Henry College